estetrol
Genito-urinary system and sex hormones (G03)Genito-urinary system and sex hormones (G03) compound in Estetra's portfolio. Molecular target: Estrogen receptor.
- Target
- Estrogen receptor
- Mechanism
- Estrogen receptor agonist
pharma · postmenopausal women with vasomotor menopausal symptoms
Estetra
Estetra SPRL
Estetra drug portfolio — 6 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Liège, BE HQ
30 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Liège, BE
- Employees
- 30
- Programs
- 1
- Drugs
- 6
- Patents
- 0
Estetra pipeline
Portfolio lens on 6 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Estetra drug portfolio — 6 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Estetra in public FDA and regional records.
-
Development asset linked to Estetra in public FDA and regional records.
-
Development asset linked to Estetra in public FDA and regional records.
-
Development asset linked to Estetra in public FDA and regional records. Molecular target: Prothrombin.
- Target
- Prothrombin
- Mechanism
- Thrombin inhibitor
-
Development asset linked to Estetra in public FDA and regional records.